<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="insights into the mechanisms underlying renal cell carcinoma (RCC) and" exact="coronavirus disease 2019" post="(COVID-19). Objective This study considers up-to-date information on the"/>
 <result pre="management of RCC and COVID-19 patients. Patient summary Amid the" exact="coronavirus disease 2019" post="(COVID-19) pandemic, patients diagnosed with renal cell carcinoma and"/>
 <result pre="Take Home Message This review provides novel biological insights into" exact="coronavirus disease 2019" post="(COVID-19)-infected patients with renal disease, with special emphasis on"/>
 <result pre="Organization (WHO) formally named the disease triggered by 2019-nCoV as" exact="coronavirus disease 2019" post="(COVID-19). The Internal Committee of Taxonomy of Viruses then"/>
 <result pre="related to severe acute respiratory syndrome (SARS) of 2003 and" exact="Middle East respiratory syndrome" post="(MERS) of 2012 [1], [2]. As of April 7,"/>
 <result pre="the current understanding of the impact of angiotensin-converting enzyme-2 (ACE2)-mediated" exact="SARS-CoV-2 infection" post="on kidney function and the therapeutic targeting of underlying"/>
 <result pre="had chronic renal disease. 3 Evidence synthesis 3.1 Mechanisms of" exact="SARS-CoV-2 infection" post="The novel zoonotic coronavirus (CoV) SARS-CoV-2 belongs to the"/>
 <result pre="target cell and is regulated by androgens (Fig. 2 )." exact="SARS-CoV infection" post="is dependent on the proteolytic activity of TMPRSS2 and"/>
 <result pre="thus making these organ sites easy routes for SARS-CoV and" exact="SARS-CoV-2 infection" post="[23]. In particular, ACE2 expression is higher in the"/>
 <result pre="available should be implemented to the suction system. COVID-19 =" exact="coronavirus disease 2019;" post="OR = operating room; PPE = personal protective equipment."/>
 <result pre="patient infected with the virus (Fig. 3 ). Fig. 3" exact="SARS-CoV-2 infection" post="in renal disease and therapeutic targeting of RCC. The"/>
 <result pre="with underlying renal disease. ACE2 = angiotensin-converting enzyme-2; COVID-19 =" exact="coronavirus disease 2019;" post="SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2. 3.5"/>
 <result pre="3.7.4 Convalescent plasma antibody transfer As tried during the 2014â€&quot;2015" exact="Ebola" post="outbreak, the use of the plasma of a recovered"/>
 <result pre="early identification, intervention, and improved prognosis among RCC patients harboring" exact="SARS-CoV-2 infection." post="As research efforts escalate globally toward the eradication of"/>
 <result pre="extent? The emerging impasse of angiotensin blockadeNephron24126202019 5GuanW.NiZ.HuY.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med38220201708172032109013 6ChenN.ZhouM.DongX.Epidemiological and clinical characteristics"/>
 <result pre="J Med38220201708172032109013 6ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 7PatelA.B.VermaA.COVID-19 and angiotensin-converting"/>
 <result pre="J Med38220202012202232227758 33Wang L, Li X, Chen H, et al." exact="SARS-CoV-2 infection" post="does not significantly cause acute renal injury: an analysis"/>
 <result pre="specimensJAMA323202018431844 73ArabiY.M.ArifiA.A.BalkyH.H.Clinical course and outcomes of critically Ill patients with" exact="Middle East respiratory syndrome" post="coronavirus infectionAnn Intern Med160201438939724474051 74RussellC.D.MillarJ.E.BaillieJ.K.Clinical evidence does not support"/>
</results>
